{{Rsnum
|rsid=4073366
|Gene=LHCGR
|Chromosome=2
|position=48755483
|Orientation=minus
|GMAF=0.2048
|Gene_s=LHCGR,STON1-GTF2A1L
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 0.0 | 27.0 | 73.0
| HCB | 11.1 | 35.6 | 53.3
| JPT | 4.5 | 29.5 | 65.9
| YRI | 0.0 | 17.7 | 82.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 11.1 | 35.6 | 53.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23883350
|Title=Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation
|OA=1
}}{{PMID Auto
|PMID=18439297
|Title=A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E epsilon4 allele.
|OA=1
}}